GenScript Hosts Inaugural APAC Distributor Meeting, Strengthening Regional Partnerships for Scientific Advancements
GenScript Hosts Inaugural APAC Distributor Meeting, Strengthening Regional Partnerships for Scientific Advancements
SINGAPORE, June 24, 2024 /PRNewswire/ -- GenScript, the world-leading biotechnology company specializing in life science research and applications, hosted the inaugural Asia-Pacific (APAC) Distributor Meeting in Nanjing, China. The event, which took place from 3rd to 6th June, brought together distributors from across the APAC region to discuss strategies, share insights, and strengthen collaborations to better serve the scientific community.
2024年6月24日,全球领先的生物技术公司GenScript在中国南京举办了首次亚太地域板块(APAC)经销商会议。该活动于6月3日开始,聚集了来自APAC地区的经销商,旨在讨论战略,分享见解,加强合作,更好地服务于科学社区。rdth来自亚太地区的与会人员齐聚经销商会议。
The comprehensive meeting agenda included keynote presentations from GenScript's executive leadership team, new product training sessions, discussions on market trends, and workshops aimed at enhancing sales and marketing strategies. The event also provided a unique platform for distributors to network, share best practices, and explore potential collaboration opportunities.
GenScript APAC总裁金海燕博士表示:“我们很高兴举办APAC经销商会议,这标志着我们加深与贵重合作伙伴的关系迈出了重要的一步。亚太地区正迅速成为科学创新中心,通过与我们的经销商合作,我们致力于促进前沿科研并为全球科学社区做出贡献。”
"We are thrilled to host our APAC Distributor Meeting, which marks a significant milestone in our efforts to deepen relationships with our valued partners," said Dr. Janice Jin, President of GenScript APAC. She continued, "The APAC region is rapidly becoming a hub for scientific innovation, and through collaborative efforts with our distributors, we are committed to facilitating cutting-edge research and contributing to the global scientific community."
会议期间,GenScript展示了最新的基因合成、蛋白工程和cGMP(Current Good Manufacturing Practice)进展。经销商还参观了新的cGMP设施,专门用于生产单向RNA(sgRNA)、非病毒DNA有效荷载和多肽。这项新开发提供了关键、优质的生物技术和制药公司所需的快速可靠的材料供应,加快了创新治疗从研究到临床应用甚至商业化的进程。
During the meeting, GenScript showcased its most recent advancements in gene synthesis, protein engineering, and cGMP (Current Good Manufacturing Practices). Distributors also toured the new cGMP facility specialized for the production of single guide RNA (sgRNA), non-viral DNA payloads and peptide. This new development offers a quick and reliable supply of essential, high-quality materials for biotech and pharmaceutical companies, accelerating the progression of innovative treatments from research to clinical application and ultimately to commercial availability.
GenScript的APAC经销商会议标志着该公司致力于与合作伙伴建立牢固的关系并持续投资亚太地区。GenScript将继续致力于通过促进科学研究来帮助科学家们实现梦想。
GenScript's APAC Distributor Meeting signifies the company's dedication to fostering strong relationships with its partners and its continuous investment in the APAC region. GenScript remains committed to empowering scientists by facilitating their research.
关于GenScript
About GenScript
更多信息,请访问GenScript生物技术的官方网站:
GenScript Biotech Corporation (HK.1548) is a world leader in technologies and services for life science R&D and manufacturing. Built upon its solid DNA synthesis technology, the company comprises four major business units: a life science services and products business unit, a biologics contract development and manufacturing organization (CDMO), an industrial synthetic products business unit, and an integrated global cell therapy company. GenScript accelerates scientific discovery and therapeutic breakthroughs for its customers. Since its founding in New Jersey, USA in 2002, GenScript has expanded its operations to serve more than 200,000 customers across 100 countries with a dedicated team of 6,900 employees. As of December 31, 2023, GenScript's services and products have been cited by 87,700 peer-reviewed journal articles worldwide. Guided by its mission to make people and nature healthier through biotechnology, GenScript strives to become the most trustworthy biotech company in the world.
药明生物(GenScript Biotech Corporation)(HK.1548)是全球生命科学研究与制造技术与服务的领先企业。作为一家建立在稳定的DNA合成技术之上的公司,GenScript由四个主要业务单元组成:生命科学服务与产品,生物制品合同开发和制造组织(CDMO),工业合成产品业务单位,以及一个综合全球细胞治疗公司。药明生物加速客户的科学发现和治疗突破。自2002年在美国新泽西成立以来,药明生物已扩大其业务范围,服务于100多个国家的超过20万名客户,拥有6900多名员工。截至2023年12月31日,药明生物的服务产品在全球已被引用了87700篇同行评议文章。以生物技术使人类和大自然更加健康为自己的使命,药明生物力图成为世界上最值得信赖的生物技术公司。
For more information, please visit GenScript Biotech's official website:
更多信息请访问GenScript生物技术官网:
Kay Chuang
Kay Chuang
Head of Marketing, GenScript
药明生物市场营销总监
[email protected]
[email protected]
SOURCE GenScript Biotech Corporation
来源: 药明生物